Do you have a strategy for responding to the temperamental IPO market and making the most of alternative financing strategies?
Foley & Lardner LLP and the NanoBusiness Alliance are pleased to invite senior business executives and investors to participate in a roundtable discussion addressing how nanotechnology companies can develop financing strategies for success.
Discussion topics include:
- Financing growth and development of a nanotechnology company with long product development timelines, little or no near-term revenue, and potential applications in many industries
- Determining when the sale of your company is the most viable and what factors have made other nanotechnology companies attractive targets
- Deciding whether to go IPO, OTC, AIM, or private equity
- Exploring nontraditional financing options
- Positioning your company for the best financing options
Confirmed Palo Alto Attendees:
- Michael Knapp, Ph.D., President and Chief Executive Officer, Cambrios
- Alexei Andreev, Managing Director, Harris & Harris Group, Inc.
- Conrad Burke, President and Chief Executive Officer, Innovalight Inc.
- Amy Corinne Smith, Senior Vice President, Global Technology Group, Lehman Brothers
- Curt Creely, Partner, Foley & Lardner LLP
People
Related Insights
July 17, 2025
Foley Viewpoints
Tricky Compliance Issues for Companies When an Executive Terminates Employment: Stock Options, Restricted Stock, and Other Equity Incentive Awards
Executive employment relationships are rarely permanent. When an executive or other senior-level employee terminates employment,…
July 17, 2025
Health Care Law Today
One Big Beautiful Bill: Slashed Budgets Will Disrupt the Medicaid Program
The new federal budget law, the One Big Beautiful Bill Act (the Act), enacted on July 4, 2025, makes dramatic changes to the Medicaid…
July 16, 2025
Foley Viewpoints
Changes to the College and University Endowment Tax
The One Big Beautiful Bill Act (OBBBA) modifies the excise tax on net investment income of private colleges and universities under…